Oppenheimer Asset Management Inc. Takes Position in Trupanion, Inc. (NASDAQ:TRUP)

Oppenheimer Asset Management Inc. bought a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 7,992 shares of the financial services provider’s stock, valued at approximately $235,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quest Partners LLC purchased a new stake in Trupanion during the 4th quarter valued at approximately $67,000. Headlands Technologies LLC purchased a new stake in Trupanion during the 2nd quarter valued at approximately $162,000. Victory Capital Management Inc. purchased a new stake in Trupanion during the 4th quarter valued at approximately $211,000. Blueshift Asset Management LLC purchased a new stake in Trupanion during the 4th quarter valued at approximately $220,000. Finally, Bayesian Capital Management LP purchased a new stake in Trupanion during the 1st quarter valued at approximately $253,000.

Wall Street Analyst Weigh In

TRUP has been the subject of several analyst reports. Northland Securities upped their price objective on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a research note on Thursday. William Blair initiated coverage on Trupanion in a research note on Friday, July 19th. They set an “outperform” rating for the company. Piper Sandler upped their price objective on Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a research note on Friday, August 9th. Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Evercore ISI raised Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Four research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.00.

Trupanion Stock Performance

Shares of TRUP stock opened at $42.80 on Monday. The company has a market cap of $1.80 billion, a price-to-earnings ratio of -66.88 and a beta of 1.74. The stock has a 50 day simple moving average of $40.56 and a 200-day simple moving average of $31.75. Trupanion, Inc. has a 12-month low of $19.14 and a 12-month high of $49.14. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. The business had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.33) EPS. On average, equities analysts forecast that Trupanion, Inc. will post -0.37 EPS for the current year.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock worth $405,238 in the last quarter. Company insiders own 5.50% of the company’s stock.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.